Skip to main content

Advances in Antibacterial Discovery

A virtual symposium on December 3, 2021


Already registered? Access the conference here.



The Advances in Antibacterial Discovery symposium will take place on Friday, December 3, 2021. The meeting will discuss the latest advances in the antibacterial drug discovery field. The symposium features talks from leading researchers and their trainees selected from recent high-profile publications. Opportunities for attendee interaction will be made available on the conference website.

This virtual symposium, hosted by the St. Jude Department of Chemical Biology and Therapeutics, is a part of the broader Bringing Chemistry to Medicine series and is supported by the St. Jude T32 Infectious Disease Therapeutics training program. 

Registration is free to facilitate participation and interaction among trainees and scientists around the world.

Register for this Symposium


Speakers to include:

Heike Brotz-Oesterhelt, PhD

Heike Brotz-Oesterhelt, PhD

University of Tuebingen 

Christoph Ernst PhD

Christoph Ernst, PhD

Deborah Hung Lab, Broad Institute, Harvard Medical School, Massachusetts General Hospital

Kristina Klobucar

Kristina Klobucar

Eric Brown Lab, McMaster University 

Paul J. Hergenrothe, PhD

Paul J. Hergenrother PhD

University of Illinois

Kim Lewis, PhD

Kim Lewis, PhD

Northeastern University

Alita A. Miller, PhD

Alita A. Miller, PhD

Entasis Therapeutics 

Stephanie M. Reeve, PhD

Stephanie M. Reeve, PhD

Richard Lee Lab, St. Jude Children's Research Hospital

image of Jeremy Rock

Jeremy Rock, PhD

Rockefeller University

Deborah T. Hung, MD, PhD

Jickky Palmae Sarathy, PhD

Thomas Dick Lab, Center for Discovery and Innovation, Hackensack Meridian Health

Jonathan Stokes, PhD

Jonathan Stokes, PhD

McMaster University



(All times are Central)

Session Speaker
Opening Remarks
8:15-8:30 am  Richard Lee, PhD 
Novel Approaches to Antimicrobial Drug Discovery
8:30-9:00 am  Alita A. Miller, PhD
9:00-9:30 am  Heike Brotz-Oesterhelt, PhD
9:30-9:40 am Break
Understanding Challenges of Permeability in Gram-negative Pathogens
9:40-10:10 am  Paul J. Hergenrother, PhD
10:10-10:35 am Kristina Klobucar
10:35-11:00 am  Stephanie M. Reeve, PhD
Networking, posters, lunch, etc
11:00am-12:00 pm  Networking, posters, lunch, etc 
Keynote/Danny Thomas Lecture Series
12:00-1:00 pm  Kim Lewis, PhD
Novel Chemical Matter to Combat Antimicrobial Resistance
1:00-1:30 pm  Jonathan Stokes, PhD
1:30-2:00 pm  Christoph Ernst, PhD
2:00-2:15 pm Break
Developments in M. Tuberculosis Drug Discovery
2:15-2:45 pm Jeremy Rock, PhD
2:45-3:15 pm  Jickky Palme Sarathy, PhD
3:15-3:45 pm Virtual Happy Hour and Round Table Discussion 
3:45-4:00 pm  Closing remarks 

About Chemical Biology and Therapeutics

The Chemical Biology and Therapeutics (CBT) Department formulates innovative chemical and chemoinformatic solutions to resolve salient problems in biology and medicine. Fundamental research programs to uncover underlying biological processes are complemented by translational centers that house chemical synthesis, screening, and computational capabilities that mirror cutting-edge biotech/pharma operations, resources rarely accessible at academic institutions. 

The expertise and resources of CBT are leveraged across the institution, making it a highly dynamic and diverse collaborative hub at St. Jude. The scientific research arm of CBT is in an exciting growth phase; individuals with bold vision and demonstrated excellence in research at the interface of Chemistry, Biology, and Medicine are encouraged to join the team.